These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23143975)

  • 1. Cancer stem cells and tumor dormancy.
    Enderling H
    Adv Exp Med Biol; 2013; 734():55-71. PubMed ID: 23143975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-initiating cells and tumor vascularization.
    Zhang LZ; Zhang CQ; Yan ZY; Yang QC; Jiang Y; Zeng BF
    Pediatr Blood Cancer; 2011 Mar; 56(3):335-40. PubMed ID: 21225908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical dependencies of tumor dormancy and progression on basic cell kinetics.
    Enderling H; Anderson AR; Chaplain MA; Beheshti A; Hlatky L; Hahnfeldt P
    Cancer Res; 2009 Nov; 69(22):8814-21. PubMed ID: 19887613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The biological features and their roles of cancer stem cells in invasion and neovascularization of cancer].
    Bian XW
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):505-6. PubMed ID: 20021957
    [No Abstract]   [Full Text] [Related]  

  • 6. A CD90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer.
    Tang KH; Dai YD; Tong M; Chan YP; Kwan PS; Fu L; Qin YR; Tsao SW; Lung HL; Lung ML; Tong DK; Law S; Chan KW; Ma S; Guan XY
    Cancer Res; 2013 Apr; 73(7):2322-32. PubMed ID: 23382045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifaceted kinetics of immuno-evasion from tumor dormancy.
    d'Onofrio A
    Adv Exp Med Biol; 2013; 734():111-43. PubMed ID: 23143978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consice review: Contribution of cancer stem cells to neovascularization.
    Ping YF; Bian XW
    Stem Cells; 2011 Jun; 29(6):888-94. PubMed ID: 21557392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-stem cancer cell kinetics modulate solid tumor progression.
    Morton CI; Hlatky L; Hahnfeldt P; Enderling H
    Theor Biol Med Model; 2011 Dec; 8():48. PubMed ID: 22208390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution and phenotypic selection of cancer stem cells.
    Poleszczuk J; Hahnfeldt P; Enderling H
    PLoS Comput Biol; 2015 Mar; 11(3):e1004025. PubMed ID: 25742563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seeing the invisible: how mathematical models uncover tumor dormancy, reconstruct the natural history of cancer, and assess the effects of treatment.
    Hanin L
    Adv Exp Med Biol; 2013; 734():261-82. PubMed ID: 23143983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epigenetic/noncoding origin of tumor dormancy.
    Crea F; Nur Saidy NR; Collins CC; Wang Y
    Trends Mol Med; 2015 Apr; 21(4):206-11. PubMed ID: 25771096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor associated stem/progenitor cells in tumorigenesis and progression of cancer].
    BIAN XW
    Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):145-6. PubMed ID: 21575381
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy.
    Kusumbe AP; Bapat SA
    Cancer Res; 2009 Dec; 69(24):9245-53. PubMed ID: 19951996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells and angiogenesis.
    Zhao Y; Bao Q; Renner A; Camaj P; Eichhorn M; Ischenko I; Angele M; Kleespies A; Jauch KW; Bruns C
    Int J Dev Biol; 2011; 55(4-5):477-82. PubMed ID: 21732274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor dormancy: long-term survival in a hostile environment.
    Quesnel B
    Adv Exp Med Biol; 2013; 734():181-200. PubMed ID: 23143980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor growth paradox and immune system-mediated selection for cancer stem cells.
    Hillen T; Enderling H; Hahnfeldt P
    Bull Math Biol; 2013 Jan; 75(1):161-84. PubMed ID: 23196354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation.
    Fantozzi A; Gruber DC; Pisarsky L; Heck C; Kunita A; Yilmaz M; Meyer-Schaller N; Cornille K; Hopfer U; Bentires-Alj M; Christofori G
    Cancer Res; 2014 Mar; 74(5):1566-75. PubMed ID: 24413534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor interstitial fluid promotes malignant phenotypes of lung cancer independently of angiogenesis.
    Li H; Li G; Liu L; Guo Z; Ma X; Cao N; Lin H; Han G; Duan Y; Du G
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1120-9. PubMed ID: 26342025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The progression of gliomas is associated with cancer stem cell phenotype.
    Kong DS; Kim MH; Park WY; Suh YL; Lee JI; Park K; Kim JH; Nam DH
    Oncol Rep; 2008 Mar; 19(3):639-43. PubMed ID: 18288395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.